The Angiotensin AT2 Receptor: Froma Binding Site to a Novel Therapeutic Target

PHARMACOLOGICAL REVIEWS

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS

1. National Institutes of Health National Heart, Lung, and Blood Institute [R01-HL136595, 2-R01-HL128189]
2. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK061578, R01-DK117495]
3. UK Global Challenge Research Fund grant from Synchrotron Techniques for African Research and Technology (START) [Science and Technology Facilities Council] [ST/R002754/1]
4. Independent Research Fund Denmark [0134-00297B]
5. Novo Nordisk Foundation [NNF19OC0058592]